UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 1, 2023, Aspen Aerogels, Inc. announced its financial results for the third quarter of 2023, which ended September 30, 2023, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1.
The information set forth in the press release, except for the information set forth under the heading “2023 Financial Outlook” and under the heading “About Aspen Aerogels, Inc.,” together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure.
The information set forth under the heading “2023 Financial Outlook” and under the heading “About Aspen Aerogels, Inc.,” together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
99.1 |
|
Press Release issued by Aspen Aerogels, Inc. on November 1, 2023 |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.
The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Aspen Aerogels, Inc. |
|
|
|
|
Date: |
November 1, 2023 |
By: |
/s/ Ricardo C. Rodriguez |
|
|
Name: |
Ricardo C. Rodriguez |
|
|
Title: |
Chief Financial Officer and Treasurer |
Exhibit 99.1
Aspen Aerogels, Inc. Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Record revenue of $60.8 million led by PyroThin® revenues of $32.8 million, up 160% quarter-over-quarter
Delivered Q3 gross profit margins of 23%, a 6-percentage point improvement over the prior quarter
NORTHBOROUGH, Mass., Nov. 1, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the third quarter of 2023, and discussed recent business developments.
Total revenue for the third quarter of 2023 was $60.8 million, compared to $36.7 million in the third quarter of last year. Net loss was $13.1 million, compared to a net loss of $29.6 million in the third quarter of last year. Net loss per share was $0.19, compared to a net loss per share of $0.75 in the third quarter of last year.
Adjusted EBITDA for the third quarter of 2023 was $(7.3) million, compared to $(23.2) million in the third quarter of last year. A reconciliation of net loss to non-GAAP Adjusted EBITDA is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Recent Business Highlights
"Our PyroThin product offering continues to gain commercial traction on the basis of our clearly differentiated and proprietary technology," commented Don Young, Aspen's President and CEO. "Our EV Thermal Barrier revenues increased by over 2.5X versus the prior quarter, and we anticipate this demand growth to continue throughout the remainder of the year and into 2024. We believe that our recent awards keep us on track to reach our goal of six confirmed OEM awards by the end of 2023, as we continue to diversify our customer base."
2023 Financial Outlook
Aspen updated its 2023 full year outlook as follows:
The Company's 2023 outlook assumes depreciation and amortization of $15.3 million, stock-based compensation expense of $10.4 million, interest income of $3.3 million and weighted average shares outstanding of 69.4 million for the full year.
A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2023 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Ricardo C. Rodriguez, Chief Financial Officer and Treasurer noted, "Our third quarter performance reflects a productive step forward towards the financial results that we are working to deliver from our existing assets and commercial arrangements."
Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2023, including those related to the planned capacity expansion, supply chain disruptions or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.
Conference Call and Webcast Notification
A conference call with Aspen management to discuss third quarter 2023 results and recent business developments will be held at 8:30 am ET on November 2, 2023. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.
Shareholders and other interested parties may call +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "607116" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.
Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides an additional financial metric that is not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measure does not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.
Management believes that this non-GAAP financial measure reflects Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that this non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. This non-GAAP measure may not be comparable to similarly titled measures presented by other companies.
The non-GAAP financial measure does not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. Aspen Battery Materials, the Company's carbon aerogel initiative, seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of EVs. Aspen's Spaceloft® products provide building owners with industry-leading energy efficiency and fire safety. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Headquartered in Northborough, Mass., Aspen manufactures its products at its East Providence, R.I. facilities. For more information, please visit www.aerogel.com.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2023 financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's 2023 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about higher than expected demand from the EV market and how it may enable a path to profitability, expectations about improvement in ability to absorb fixed costs and reduction of conversion costs as a percentage of sales and the same leading to target revenue capacity and gross margins and Adjusted EBITDA margins; Aspen's expectations regarding the planned second manufacturing plant in Georgia ("Plant II"), the extended construction and commissioning timeframe for Plant II, Aspen's efforts to manage the construction of Plant II to align with our expectations of demand from EV customers, and the use of contract manufacturers to meet demand from Energy Industrial customers; beliefs about the general strength, weakness or health of Aspen's business; acceleration in demand; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the electric vehicle market; beliefs about Aspen's ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's electric vehicle opportunities, including the EV thermal barrier business; beliefs about revenue growth and profitability; beliefs about the performance of PyroThin® including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen's ability to expand the market for PyroThin®, to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen's thermal barrier design, prototype, quoting and assembly activities; and expectations about the cost of the capital projects, including Plant II. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to execute the growth plan, inability to complete construction and commissioning the Plant II and to do so at a cost consistent with Aspen's estimates and aligned with Aspen's expectations of demand from our EV customers; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen's inability to create customer or market opportunities for, including PyroThin®; any other battery performance and safety products, battery materials or for other new products developed from Aspen's aerogel technology; any disruption or inability to achieve expected capacity levels in any of the three existing production lines in East Providence, RI or the Mexico assembly facility or at any contract manufacturer; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading "Risk Factors" in Aspen's Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the Securities and Exchange Commission ("SEC") on March 16, 2023, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.
ASPEN AEROGELS, INC. Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
|
||||||||
|
|
September 30, |
|
|
December 31, |
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
(In thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
94,643 |
|
|
$ |
281,335 |
|
Restricted cash |
|
|
320 |
|
|
|
1,226 |
|
Accounts receivable, net |
|
|
54,413 |
|
|
|
57,350 |
|
Inventories |
|
|
34,421 |
|
|
|
22,538 |
|
Prepaid expenses and other current assets |
|
|
16,568 |
|
|
|
7,236 |
|
Total current assets |
|
|
200,365 |
|
|
|
369,685 |
|
Property, plant and equipment, net |
|
|
385,026 |
|
|
|
259,223 |
|
Operating lease right-of-use assets |
|
|
17,400 |
|
|
|
11,990 |
|
Other long-term assets |
|
|
2,355 |
|
|
|
2,518 |
|
Total assets |
|
$ |
605,146 |
|
|
$ |
643,416 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
37,115 |
|
|
$ |
54,728 |
|
Accrued expenses |
|
|
16,694 |
|
|
|
16,003 |
|
Deferred revenue |
|
|
5,463 |
|
|
|
5,846 |
|
Operating lease liabilities |
|
|
1,986 |
|
|
|
2,368 |
|
Total current liabilities |
|
|
61,258 |
|
|
|
78,945 |
|
Convertible note - related party |
|
|
112,088 |
|
|
|
103,580 |
|
Operating lease liabilities long-term |
|
|
21,987 |
|
|
|
13,456 |
|
Total liabilities |
|
|
195,333 |
|
|
|
195,981 |
|
Stockholders' equity: |
|
|
|
|
|
|
||
Total stockholders' equity |
|
|
409,813 |
|
|
|
447,435 |
|
Total liabilities and stockholders' equity |
|
$ |
605,146 |
|
|
$ |
643,416 |
|
ASPEN AEROGELS, INC. Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, |
|
|
September 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
|
(In thousands, except |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue |
|
$ |
60,755 |
|
|
$ |
36,706 |
|
|
$ |
154,499 |
|
|
$ |
120,753 |
|
Cost of revenue |
|
|
46,945 |
|
|
|
43,065 |
|
|
|
127,196 |
|
|
|
130,111 |
|
Gross profit (loss) |
|
|
13,810 |
|
|
|
(6,359) |
|
|
|
27,303 |
|
|
|
(9,358) |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
|
4,218 |
|
|
|
4,694 |
|
|
|
12,281 |
|
|
|
12,733 |
|
Sales and marketing |
|
|
8,386 |
|
|
|
7,293 |
|
|
|
24,226 |
|
|
|
20,944 |
|
General and administrative |
|
|
15,840 |
|
|
|
9,963 |
|
|
|
41,382 |
|
|
|
26,544 |
|
Total operating expenses |
|
|
28,444 |
|
|
|
21,950 |
|
|
|
77,889 |
|
|
|
60,221 |
|
Loss from operations |
|
|
(14,634) |
|
|
|
(28,309) |
|
|
|
(50,586) |
|
|
|
(69,579) |
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense, convertible note - related party |
|
|
(1,938) |
|
|
|
(1,734) |
|
|
|
(2,424) |
|
|
|
(4,103) |
|
Interest income, net |
|
|
1,313 |
|
|
|
448 |
|
|
|
5,532 |
|
|
|
553 |
|
Income from Employee Retention Credits |
|
|
2,186 |
|
|
|
- |
|
|
|
2,186 |
|
|
|
- |
|
Total other income (expense), net |
|
|
1,561 |
|
|
|
(1,286) |
|
|
|
5,294 |
|
|
|
(3,550) |
|
Net loss |
|
$ |
(13,073) |
|
|
$ |
(29,595) |
|
|
$ |
(45,292) |
|
|
$ |
(73,129) |
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic and diluted |
|
$ |
(0.19) |
|
|
$ |
(0.75) |
|
|
$ |
(0.65) |
|
|
$ |
(2.03) |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic and diluted |
|
|
69,317,805 |
|
|
|
39,533,695 |
|
|
|
69,243,843 |
|
|
|
36,047,879 |
|
Analysis of Cash Flow |
||||||||||||
The following table summarizes our cash flows for the periods indicated. |
||||||||||||
|
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
March 31, 2023 |
|
|
June 30, 2023 |
|
|
September 30, 2023 |
|
|||
|
|
($ in thousands) |
|
|||||||||
Net cash provided by (used in): |
|
|
|
|
|
|
|
|
|
|||
Operating activities |
|
$ |
(24,651) |
|
|
$ |
(7,680) |
|
|
$ |
(7,502) |
|
Investing activities |
|
|
(49,378) |
|
|
|
(66,012) |
|
|
|
(32,279) |
|
Financing activities |
|
|
(364) |
|
|
|
142 |
|
|
|
126 |
|
Net (decrease) increase in cash |
|
|
(74,393) |
|
|
|
(73,550) |
|
|
|
(39,655) |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
282,561 |
|
|
|
208,168 |
|
|
|
134,618 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
208,168 |
|
|
$ |
134,618 |
|
|
$ |
94,963 |
|
Square Foot Operating Metric |
||||||||||||||||
The following chart sets forth Energy Industrial product shipments in square feet associated with recognized revenue. |
||||||||||||||||
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, |
|
|
September 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
|
(In thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Energy Industrial product shipments in square feet |
|
|
5,909 |
|
|
|
6,711 |
|
|
|
22,337 |
|
|
|
24,074 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Net loss to Adjusted EBITDA
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three and nine months ended September 30, 2023 and 2022: |
||||||||||||||||
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, |
|
|
September 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Net loss |
|
$ |
(13,073) |
|
|
$ |
(29,595) |
|
|
$ |
(45,292) |
|
|
$ |
(73,129) |
|
Depreciation and amortization |
|
|
4,550 |
|
|
|
2,531 |
|
|
|
10,757 |
|
|
|
6,692 |
|
Stock-based compensation |
|
|
2,789 |
|
|
|
2,590 |
|
|
|
7,766 |
|
|
|
6,713 |
|
Other (income) expense |
|
|
(1,561) |
|
|
|
1,286 |
|
|
|
(5,294) |
|
|
|
3,550 |
|
Adjusted EBITDA |
|
$ |
(7,295) |
|
|
$ |
(23,188) |
|
|
$ |
(32,063) |
|
|
$ |
(56,174) |
|
For the 2023 full year financial outlook: |
||||||||
|
||||||||
|
|
Year Ending |
|
|||||
|
|
December 31, 2023 |
|
|||||
|
|
Low |
|
|
High |
|
||
|
|
(In thousands) |
|
|||||
Net loss |
|
$ |
(62,400) |
|
|
$ |
(52,400) |
|
Depreciation and amortization |
|
|
15,300 |
|
|
|
15,300 |
|
Stock-based compensation |
|
|
10,400 |
|
|
|
10,400 |
|
Other (income) expense |
|
|
(3,300) |
|
|
|
(3,300) |
|
Adjusted EBITDA |
|
$ |
(40,000) |
|
|
$ |
(30,000) |
|
CONTACT: Investor Relations & Media Contacts: Neal Baranosky, Phone: (508) 691-1111 x 8, nbaranosky@aerogel.com; Georg Venturatos / Jared Gornay, Gateway Group, ASPN@gateway-grp.com, Phone: (949) 574-3860
Document And Entity Information |
Nov. 01, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 01, 2023 |
Entity Registrant Name | Aspen Aerogels, Inc. |
Entity Central Index Key | 0001145986 |
Entity Emerging Growth Company | false |
Securities Act File Number | 001-36481 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 04-3559972 |
Entity Address, Address Line One | 30 Forbes Road |
Entity Address, Address Line Two | Building B |
Entity Address, City or Town | Northborough |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 01532 |
City Area Code | (508) |
Local Phone Number | 691-1111 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ASPN |
Security Exchange Name | NYSE |
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end
Q%2OTO^LM^<)-J _1>
M"8ZQN%9XSWFIW8(*!T*F3Z)+,LUVRZN;'Z-TK+PF\)GS7=?EWAOF?(*,CF;(
M6]N+*% T[]N^=VLC<:/6QI6/_N
M,1%6N3?1WT9P/5+N0GX^?VR^K;EKK+Z@\F6WTX=]E0L#Q]=W#2J&:.O7*[BHX4[3XK\&'L)Z;M8S8$OO3C%+#B)
M5\SU/$@P$K@(F+CD:,5%C] Y,&$1L?^FG;!RO31?">0RZ+(7U!Z]@H%C\)\R
M=8&>]YVJZT +WL>CN>PU A=1JBY%646IEO:@;MX!#HL$I&B %SA%!?JJ31"VV^=C-QY]ZSUTF